论文信息 - Establishment of timetables for the phasing out of animal experiments for cosmetics Carcinogenicity

Establishment of timetables for the phasing out of animal experiments for cosmetics Carcinogenicity

Procter and Gamble, USA; ECVAM-JRC, Italy; Cognis Deutschland GmbH & Co. KG, Germany; TNO Nutrition and Food Research, The Netherland; 5 SCCNFP and EFSA, Bruxelles, Belgium; University of Pisa, Italy; National Agency for Medicines, Helsinki and Department of Pharmacology and Toxicology, University of Oulu, Finland; 8 Wella AG, Germany; Research Animals Department RSPCA, UK; PCS Consultant Ltd, CH4132 Switzerland, Institute for Cancer Research, Norway; Johnson and Johnson, Belgium.

[1] R. Cardiff,et al. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[2] V. Thybaud,et al. Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens. , 1999, Mutagenesis.